CMS rescinds retroactive revocation of Novocure's Medicare billing privileges

NovoCure Ltd

CMS revoked billing privileges retroactive to Dec 17, 2025; cited administrative re-validation issue, not substantive failure.
On Feb 24, 2026, CMS rescinded revocation and reinstated privileges retroactively to Dec 17, 2025.
Company continued patient services during revocation and expects no impact on revenue recognition.
Revocation letter dated Jan 29, 2026; resolution achieved within one month.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.